Long-chain fatty acids and short-chain fatty acids in exhaled breath condensate of patients with chronic obstructive pulmonary disease

   
Karavaeva T.M.1 , Maksimenya M.V.1, Tereshkov P.P.1, Gaimolenko I.N.1, Medvedeva T.A.1, Parshina A.A.1

1. Chita State Medical Academy, Chita, Russia
Section: Clinical and Diagnostic Research
DOI: 10.18097/PBMC20216702169      PubMed Id: 33860775
Year: 2021  Volume: 67  Issue: 2  Pages: 169-174
In present study we performed gas-liquid chromatographic analysis of exhaled breath condensate to measure volatile fatty acids (C2 — acetic, C3 — propionic, C4 — butanoic, isoC4 — isobutyric, C5 — valerianic, C6 — caproic, C7 — heptanoic) and fatty acid with a long aliphatic chain (C14:0 — myristic, C15:0 — pentadecanoic, C16:0 — palmitic, C16:1 — palmitooleic, C17:0 — heptadecanoic, C17:1 — heptadecenoic, C18:0 — stearic, C18:1 — oleic, C18:2 — linolenic, C18:3ω3 — α-linolenic, C20:4ω6 — arachidonic) in patients suffering from moderate chronic obstructive pulmonary disease (2nd stage, GOLD). We revealed the increase of the total amount of short chain fatty acids (C2, C3, C4, C5) and polyunsaturated (C18:2, C20:4ω6) fatty acids, meanwhile the level of saturated fatty acids (C16:0, C17:0, C18:0) decreased.
Download PDF:  
Keywords: long chain fatty acid, volatile fatty acids, short chain fatty acids, expirate, chronic obstructive pulmonary disease
Citation:

Karavaeva, T. M., Maksimenya, M. V., Tereshkov, P. P., Gaimolenko, I. N., Medvedeva, T. A., Parshina, A. A. (2021). Long-chain fatty acids and short-chain fatty acids in exhaled breath condensate of patients with chronic obstructive pulmonary disease. Biomeditsinskaya Khimiya, 67(2), 169-174.
References  
 2024 (vol 70)
 2023 (vol 69)
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)